Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To determine whether intranasal steroid treatment inhibits the increased sensitivity to histamine that occurs 24 hours after nasal antigen challenge, 12 allergic volunteers were entered into a double-blind study comparing placebo or 164 micrograms of beclomethasone dipropionate twice a day for 7 days. Beclomethasone dipropionate partially reduced the early mediator response to antigen and the influx of eosinophils 24 hours later. Comparing the initial histamine challenge with that done 24 hours after antigen with the subjects on placebo, there was a significant increase in sneezes, TAME-esterase activity, and albumin. Pretreatment with intranasal beclomethasone dipropionate resulted in a reduced response to histamine 24 hours after antigen challenge. A positive correlation occurred between the number of eosinophils in the lavage before histamine challenge and the level of TAME-esterase activity (rs = 0.67, p = 0.03) during the histamine challenge that followed antigen with the subjects on placebo. We thus confirmed the increase in nonspecific nasal airway responsiveness 24 hours after antigen challenge, with a concomitant increase in eosinophils, and demonstrate its inhibition by pretreatment with intranasal steroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pipkorn, U., Proud, D., Lichtenstein, L. M., Kagey-Sobotka, A., Norman, P. S., & Naclerio, R. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162403 · Cited by 255
Self-citation
Cited by
Clinical Practice Guideline: Allergic Rhinitis
Seidman, M. D., Gurgel, R. K., Lin, S. Y., Schwartz, S. R., Baroody, F. M., Bonner, J. R., Dawson, D. E., Dykewicz, M. S., Hackell, J. M., Han, J. K., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599814561600 · Cited by 671
“INS also reduce the antigen-induced hyperresponsiveness of the nasal mucosa to subsequent challenge by antigen(123) and histamine release.(124,125) Placebo-controlled clinical trials demonstrate the effectiveness of INS in the reduction of nasal symptoms including sneezing, itching, rhinorrhea, and congestion in adult…”
BackgroundSelf-citationInternational Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Self-citationRhinitis and asthma: Evidence for respiratory system integration
Togias, A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1592 · Cited by 471
The diagnosis and management of sinusitis: A practice parameter update
Slavin, R. G., Spector, S. L., Bernstein, I. L., Slavin, R. G., Kaliner, M. A., Kennedy, D. W., Virant, F. S., Wald, E. R., Khan, D. A., Blessing-Moore, J., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.048 · Cited by 378
Metadata
- Authors
- Baroody, F. M., Cruz, A. A., Lichtenstein, L. M., Kagey-Sobotka, A., Proud, D., & Naclerio, R. M.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 1992-09
- Volume
- 90
- Issue
- 3
- Pages
- 373-376
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W1974430487
- Cited by
- 47
- References
- 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. https://app.cochat.ai/papers/10.1016/s0091-6749(05)80017-x
- The paper
- Baroody, F. M., Cruz, A. A., Lichtenstein, L. M., Kagey-Sobotka, A., Proud, D., & Naclerio, R. M. (1992). Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/s0091-6749(05)80017-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.